The Needle and the Nation: How Ozempic, Wegovy, Mounjaro, and other GLP-1 drugs are quietly deflating America’s wasteline
According to the Gallup National Health and Well-Being Index, America’s adult obesity rate has fallen to 37% in 2025, down from 39.9% in 2022 — a small but significant drop after decades of stagnation. Over the same period, the number of people taking injectable anti-obesity drugs more than doubled, from 5.8% to 12.4%. Coincidence? Perhaps. […]
Glucagon-Like Peptide-1 Analogues Market to Surpass USD 299.08 Billion by 2033, Fueled by the Weight Management and Diabetes Revolution | DataM Intelligence
AUSTIN, Texas and TOKYO, Oct. 28, 2025 /PRNewswire/ — According to DataM Intelligence, the Glucagon-like Peptide-1 (GLP-1) Analogues Market is witnessing a transformative expansion, driven by soaring demand for effective obesity management and type 2 diabetes therapies. The GLP-1…
Found Health Launches GLP-1 Microdosing Program for Early Metabolic Dysfunction
MIAMI–(BUSINESS WIRE)–Found, the doctor-designed telehealth platform specializing in personalized weight care since 2019, today announced the launch of its GLP-1 Microdosing Program. The program addresses a critical gap in preventive care: patients with early metabolic dysfunction often wait years for treatment until their condition worsens to meet traditional prescribing thresholds. “For too long, healthcare has […]
Obesity Rate Declining in U.S.
The U.S. obesity rate is showing signs of abating from its 2022 high. GLP-1 antidiabetic injectables used for weight loss may be playing a role.
GLP-1s May Lower Cardiac, Mortality Risks in PsA Patients
Although findings from a large retrospective study supports these positive effects of taking a GLP-1, it’s unclear whether they come from weight loss alone or the drug itself. Medscape Medical News
Weight loss drugs are bringing down the country’s obesity rate, a survey shows
The Gallup National Health and Well-Being Index shows that GLP-1 weight loss drugs are having an effect: The U.S. obesity rate is at 37%, down from 39.9%. (Image credit: Dobrila Vignjevic/Getty Images)
Nutritionists reveal the $5 food to eat every day to lose weight without Ozempic
Dr Hillary Lin, a nutritionist based out of New York, says that this cheap ingredient increases the hormone GLP-1 in your body, which is the same hormone that drugs like Ozempic mimic.
Innovent, Lilly’s mazdutide trumps Novo’s semaglutide in head-to-head diabetes, weight loss study
Innovent’s Eli Lilly-partnered mazdutide, a GLP-1/glucagon (GCG) dual receptor agonist, displayed broader effects on patients’ blood glucose levels and weight loss than Novo’s leading GLP-1 semaglutide in a head-to-head trial.
Why Ozempic and Wegovy Don’t Cause Weight Loss for Everyone
Scientists look to genetics to explain why GLP-1 drugs work for some people but not for others
How does front end innovation work at Givaudan? In conversation with Alexandre Bastos
What is “front-end innovation” and how is it structured at global flavors and fragrances giant Givaudan? “Our teams can [assess] one [startup] here and another there, but the 1,000 companies we see every year, it’s more coming from accelerators, VC investors and other scouters that are out there looking for our needs,” says Alexandre Bastos, […]